ClinicalTrials.Veeva

Menu

MILC: A Comprehensive Mobile Application That Addresses the Breastfeeding Challenges of Low-income Hispanic Mothers

B

Benten Technologies

Status

Not yet enrolling

Conditions

Breastfeeding, Exclusive

Treatments

Behavioral: Usual care
Behavioral: MILC application

Study type

Interventional

Funder types

Other
Industry
NIH

Identifiers

NCT06520696
MILC
R44MD017174 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The innovative platform MILC is designed to provide an integrated and comprehensive professional and social support network with personalized breastfeeding (BF) education to target exclusive breastfeeding (EBF) and any BF behaviors in low-income Hispanic women. Formative research conducted for the development of MILC and results from pilot testing will help guide the completion of the development and testing of this prototype that specifically caters to Hispanic women. In the long term, MILC has the potential to increase the rates of EBF and any BF up to 12 months.

Full description

Breastfeeding (BF) is positively associated with health benefits for infants. It reduces an infant's risks for various conditions such as respiratory tract infections, non-specific gastroenteritis, diarrhea, asthma, and sudden infant death syndrome (SIDS).

Despite high breastfeeding (BF) initiation of approximately 80% among the Hispanic population in the United States (US), less than 25% of infants were exclusively breastfed (EBF) through 6 months, further perpetuating ethnic disparities in chronic diseases such as diabetes, obesity, and hypertension. Hispanic women are more likely to supplement feeding with formula, than non-Hispanic or African American (AA) mothers. Research has reported that barriers such as insufficient BF education, lack of BF technical support (i.e. latching issues, sore nipples), returning to work, easy access to free or discounted formula milk from Women Infants and Children (WIC), lack of social support, perceived inconvenience, cultural belief that both formula and breastmilk (los-dos) is best for the babies, perception that the infant is not satiated, and embarrassment associated with breastfeeding result in premature weaning off BF among low-income Hispanic mothers. Therefore, increasing the duration of EBF and continuous BF among low-income Hispanic women would require an innovative and comprehensive approach that addresses the diverse range of barriers listed above.

The investigators hypothesize that MILC will show significantly higher percentages of BF mothers in the intervention group at each time (1 month, 3 months, and 6 months) point compared with the control group. In the short term, MILC will be shown to be usable and acceptable by Hispanic BF mothers to receive BF support, education, and guidance from primary care providers (PCP) and certified lactation consultants/international board certified lactation consultants (CLC/IBCLC). In the long term, the impact of MILC will increase the rates of EBF for up to 6 months along with increasing rates of any BF up to 12 months.

Enrollment

178 estimated patients

Sex

Female

Ages

18 to 44 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria for focus groups:

  • Mothers who successfully exclusively breastfed for up to 6 months, at least one child OR mothers who attempted EBF but were unsuccessful at breastfeeding, in the past 3 years
  • Self-identify as Hispanic
  • Be WIC-eligible
  • Voluntarily consent
  • Speak English

Inclusion Criteria for Randomized Control Trial (RCT):

  • In their late third trimester (approximately 4 weeks from delivery)
  • Can initiate BF immediately
  • Self-identify as Hispanic
  • Be WIC-eligible
  • Voluntarily consent
  • Not have psychiatric hospitalization within the last 3 months
  • Not have current or suicidal thoughts or past attempts
  • Own a smartphone device
  • Speak English

Exclusion Criteria for focus groups and Randomized Control Trial (RCT):

  1. Participants who are under the age of 18 or over 44

  2. Women experiencing a fetal demise or infant death

  3. Women who report the following conditions also will be excluded:

    • Human immunodeficiency virus (HIV)
    • Taking antiretroviral medication or chemotherapy agents
    • Untreated, active tuberculosis
    • T-Cell lymphotropic virus type I or type II
    • Illicit drug use
    • Receiving radiation therapy
    • Exposed to anthrax
    • Undergone breast surgery
    • Known exposure to environmental toxins
    • Active hepatitis B and C
    • Prescription drug use incompatible with lactation

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

178 participants in 2 patient groups

Intervention group: MILC application
Experimental group
Description:
Eligible Hispanic participants in their third trimester will be recruited for the study. The intervention group will receive standard WIC services plus the MILC application.
Treatment:
Behavioral: MILC application
Control Group: Usual Care
Experimental group
Description:
Participants in the control group will receive care as usual with standard breastfeeding services from the WIC program.
Treatment:
Behavioral: Usual care

Trial contacts and locations

3

Loading...

Central trial contact

Katie Chang, MS; Tony Ma, MS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems